Mesenchymal stromal cells improve human islet function through released products and extracellular matrix

Area of Science:

• Cell Biology
• Transplantation Immunology
• Endocrinology

Background:

• Mesenchymal stromal cells (MSCs) show promise in improving islet function.
• Translating these findings from rodent models to human clinical applications is crucial for transplantation therapy.

Purpose of the Study:

• To investigate the effects of human MSCs on human islet function for transplantation.
• To identify the specific MSC-derived factors responsible for these beneficial effects.

Main Methods:

• Human islets were co-cultured with human adipose-derived MSCs (hASCs) or treated with MSC-derived extracellular matrix (ECM) and annexin A1 (ANXA1).
• Islet insulin secretion was measured using radioimmunoassay.
• Gene expression analysis identified potential MSC-islet receptor interactions.

Main Results:

• Co-culture with hASCs significantly improved human islet secretory function in vitro.
• MSC-derived ECM and ANXA1 partially mediated these beneficial effects on islet function.

Conclusions:

• Human MSCs can enhance the quality of human islets for Type 1 diabetes transplantation.
• Cell-free strategies using MSC-derived ANXA1 and ECM may improve islet quality for transplantation.